Abstract
More than 30 years ago, extracorporeal treatment was used in the intensive care unit (ICU) for the first time in order to deliver hemodialysis. Due to improvements in medical and surgical standards of care and an increase in the average age of patients, clinicians are today facing a significant increase in patients’ severity of illness at ICU admission and the frequent occurrence of multiple organ failure (MOF) with the simultaneous dysfunction of two or more organs. Extracorporeal treatments to support different organs (kidneys, liver, lungs, heart, septic blood) are now common in the ICU. However, paralleling the evolution of continuous dialytic treatments over the last two decades, in recent years, multiple organ support therapy (MOST) has been delivered as a “Christmas-tree like” addition of one system on another (e.g., continuous renal replacement therapy [CRRT] on extracorporeal membrane oxygenation [ECMO] or molecular adsorbent recycling system [MARS] on CRRT). Current developments and the future of MOST foresee the application of dedicated and integrated multipurpose advanced platforms for the support of patients with MOF. This review will detail extracorporeal blood purification treatments that can be delivered for dysfunction of organs other than the kidneys.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vincent J, Opal S, Marshall J, Tracey K (2013) Sepsis definitions: time for change. Lancet 381:774–775
Kaukonen K-M, Bailey M, Suzuki S et al (2014) Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 311:1308–1316
Remick DG (2011) The pathogenesis of sepsis. Annu Rev Pathol 6:19–48
Lonneman G (1999) Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int 56:S84–S87
Lehner GF, Wiedermann CJ, Joannidis M (2014) a systematic review and meta-analysis. Minerva Anestesiol 80:595–609
Borthwick E, Hill C, Rabindranath K et al (2013) High-volume haemofiltration for sepsis. Cochrane Database Syst Rev 1:CD008075
Clark E, Molnar AO, Joannes-Boyau O et al (2014) High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care 18:R7
Marshall JC, Foster D, Vincent JL et al (2004) Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 190:527–534
Cruz DN, Antonelli M, Fumagalli R, Foltran F (2009) Early use of polymyxin b hemoperfusion in abdominal septic shock. JAMA 301:2445–2452
Payen DM, Guilhot J, Launey Y et al (2015) Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 41:975–984
Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group (2014) Polymyxin B hemoperfusion in clinical practice: The picture from an unbound collaborative registry. Blood Purif 37:22–25
Connolly A, Vernon D (2000) Manipulations of the metabolic response for management of patients with severe surgical illness: review. World J Surg 24:696–704
Villa G, Zaragoza JJ, Sharma A et al (2014) Cytokine removal with high cut-off membrane: review of literature. Blood Purif 38:167–173
Villa G, Chelazzi C, Valente S et al (2014) Hemodialysis with high cutoff membranes improves tissue perfusion in severe sepsis: preliminary data of the Sepsis in Florence sTudy (SIFT). Crit Care 18:401
Ronco C (2014) Standard nomenclature for renal replacement therapy in acute kidney injury: very much needed! Blood Purif 38:37–38
Hotchkiss RS, Monneret G, Payen D (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 13:862–874
Ronco C, Brendolan A, Lonnemann G et al (2002) A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30:1250–1255
Formica M, Olivieri C, Livigni S et al (2003) Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med 29:703–708
Bellomo R, Tetta C, Ronco C (2003) Coupled plasma filtration adsorption. Intensive Care Med 29:1222–1228
Livigni S, Bertolini G, Rossi C et al (2014) Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial. BMJ open 4:e003536
Mariano F, Morselli M, Holló Z et al (2015) Citrate pharmacokinetics at high levels of circuit citratemia during coupled plasma filtration adsorption. Nephrol Dial Transplant 30:1911–1919
Bone R, Balk R, Cerra F et al (2009) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 136(5 Suppl):e28
Liu KD, Matthay M (2008) Advances in critical care for the nephrologist: Acute lung injury/ARDS. Clin J Am Soc Nephrol 3:578–586
Esteban A, Alía I, Gordo F et al (2000) Prospective randomized trial ventilation and volume-controlled ventilation in ARDS. Chest 117:1690–1696
Dasta JF, Mclaughlin TP, Mody SH, Piech CT (2005) Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 33:1266–1271
Vieira JM, Castro I, Curvello-Neto A et al (2007) Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients. Crit Care Med 35:184–191
Kuiper JW, Groeneveld BJ, Slutsky AS, Plötz FB (2005) Mechanical ventilation and acute renal failure. Crit Care Med 33:1408–1415
Slutsky A, Ranieri V (2013) Ventilator-induced lung injury. N Engl J Med 369:2126–2136
Tremblay L, Slutsky A (1998) Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 110:482–488
Kuiper JW, Vaschetto R, Della Corte F et al (2011) Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release – just theory or a causal relationship? Crit Care 15:228
ARDSNetwork (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
Fitzgerald M, Millar J, Blackwood B et al (2014) Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Crit Care 18:222
Serpa Neto A, Simonis FD, Barbas CSV et al (2015) Lung-protective ventilation with low tidal volumes and the occurrence of pulmonary complications in patients without acute respiratory distress syndrome. Crit Care Med 28:1
Futier E, Jaber S (2014) Lung-protective ventilation in abdominal surgery. Curr Opin Crit Care 20:426–430
Feihl F, Perret C (1998) Permissive hypercapnia. European Respiratory Monograph 3:162–173
Contreras M, Masterson C, Laffey J (2015) Permissive hypercapnia: what to remember. Curr Opin Crit Care 18:26–37
Brian JJ (1998) Carbon dioxide and the cerebral circulation. Anesthesiology 88:1365–86
Doerr CH, Gajic O, Berrios JC et al (2005) Hypercapnic acidosis impairs plasma membrane wound reseating in ventilator-injured lungs. Am J Respir Crit Care Med 171:1371–1377
Curley G, Contreras M, Nichol A et al (2010) Hypercapnia and acidosis in sepsis: a double-edged sword? Anesthesiology 112:462–472
Isobe J, Mizuno H, Matsunobe S et al (1989) A new type of low blood flow ECCO2R using a hemodialysis system in apneic states. ASAIO Trans 35:638–639
Nolte SH, Jonitz WJ, Grau J et al (1989) Hemodialysis for extracorporeal bicarbonate/CO2 removal (ECBicCO2R) and apneic oxygenation for respiratory failure in the newborn. Theory and preliminary results in animal experiments. ASAIO Trans 35:30–34
Quinnell TG, Pilsworth S, Shneerson JM, Smith IE (2006) Prolonged invasive ventilation following acute ventilatory failure in COPD: weaning Results, survival, and the role of noninvasive ventilation. Chest 129:133–139
Menzies R, Gibbons W, Goldberg P (1989) Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure. Chest 95:398–405
Bein T, Weber-Carstens S, Goldmann A et al (2013) Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus “conventional” protective ventilation (6 ml/kg) in severe ARDS: The prospective randomized Xtravent-study. Intensive Care Med 39:847–856
Cove ME, MacLaren G, Federspiel WJ, Kellum J (2012) Bench to bedside review: Extracorporeal carbon dioxide removal, past present and future. Crit Care 16:232
Bein T, Weber F, Philipp A et al (2006) A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 34:1372–1377
Del Sorbo L, Pisani L, Filippini C et al (2013) Extracorporeal CO2 removal in Hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med 43:120–127
Ricci Z, Romagnoli S, Ronco C (2014) Extracorporeal support therapies. In: Miller R (ed) Miller’s Anesthesia, 2-Volume Set, 8th edn. Elsevier, Philadelphia, pp 3158–3181
MacLaren G, Combes A, Bartlett R (2011) Respiratory dialysis is not extracorporeal membrane oxygenation. Crit Care Med 39:2787–2788
Young J, Dorrington K, Blake G, Ryder W (1992) Femoral arteriovenous extracorporeal carbon dioxide elimination using low blood flow. Crit Care Med 20:805–809
Godet T, Combes A, Zogheib E et al (2015) Novel CO2 removal device driven by a renal-replacement system without hemofilter. A first step experimental validation. Anaesth Crit Care Pain Med 34:135–140
Forster C, Schriewer J, John S et al (2013) Low-flow CO2 removal integrated into a renal-replacement circuit can reduce acidosis and decrease vasopressor requirements. Crit Care 17:R154
Quintard JM, Barbot O, Thevenot F, de Matteis O, Benayoun L, Leibinger F (2014) Partial extracorporeal carbon dioxide removal using a standard continuous renal replacement therapy device. ASAIO J 60:564–569
Siddiqui MS, Stravitz RT (2014) Intensive care unit management of patients with liver failure. Clin Liver Dis 18:957–978
Fagundes C, Ginès P (2012) Hepatorenal syndrome: A severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis 59:874–885
Naka T, Wan L, Bellomo R et al (2004) Kidney failure associated with liver transplantation or liver failure: the impact of continuous veno-venous hemofiltration. Int J Artif Organs 27:949–955
Patel S, Wendon J (2012) Regional citrate anticoagulation in patients with liver failure – time for a rethink? Crit Care 16:153
Leventhal TM, Liu KD (2015) What a nephrologist needs to know about acute liver failure. Adv Chronic Kidney Dis 22:376–381
Larsen FS, Schmidt LE, Bernsmeier C et al (2016) High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. J Hepatol 64:69–78
Willars C (2014) Update in intensive care medicine: acute liver failure. Initial management, supportive treatment and who to transplant. Curr Opin Crit Care 20:202–209
Saliba F, Camus C, Durand F et al (2013) Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure. Ann Intern Med 159:522–531
Palazzuoli A, Ruocco G, Ronco C, McCullough P (2015) Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney. Crit Care 19:296
Nalesso F, Garzotto F, Ronco C (2010) Technical aspects of extracorporeal ultrafiltration: Mechanisms, monitoring and dedicated technology. Contrib Nephrol 164:199–208
Ronco C, Haapio M, House A (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539
McMurray JJV, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 33:1787–1847
Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675–683
Bart BA, Goldsmith SR, Lee KL et al (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367:2296–2304
Marenzi G, Muratori M, Cosentino ER et al (2014) Continuous ultrafiltration for congestive heart failure: The CUORE trial. J Card Fail 20:9–17
Krishnamoorthy A, Felker GM (2014) Fluid removal in acute heart failure: diuretics versus devices. Curr Opin Crit Care 20:478–483
Goldsmith SR, Bart BA, Burnett J (2014) Decongestive therapy and renal function in acute heart failure: Time for a new approach? Circ Heart Fail 7:531–535
Lala A, McNulty SE, Mentz RJ et al (2015) Relief and recurrence of congestion during and after hospitalization for acute heart failure. Circ Heart Fail 8:741–748
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ricci, Z., Romagnoli, S., Ronco, C. (2016). (Multiple) Organ Support Therapy Beyond AKI. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2016. Annual Update in Intensive Care and Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-27349-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-27349-5_11
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27348-8
Online ISBN: 978-3-319-27349-5
eBook Packages: MedicineMedicine (R0)